SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-11-061736
Filing Date
2011-12-22
Accepted
2011-12-22 16:00:46
Documents
1
Period of Report
2011-12-20

Document Format Files

Seq Description Document Type Size
1 DAVIS 122011 FORM 4 rrd328662.html 4  
1 DAVIS 122011 FORM 4 rrd328662.xml 4 3684
  Complete submission text file 0001181431-11-061736.txt   5178
Mailing Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421
Business Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Issuer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address NEUROGEN CORP 35 NORTHEAST INDUSTRIAL RD BRANFORD CT 06405
Business Address
DAVIS STEPHEN (Reporting) CIK: 0001131146 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23155 | Film No.: 111277497